Search - tctmd.com

Displaying 161 - 180 of 207

Sort: Relevancy | Date

News Conference News EuroPCR 2015

CT-Derived FFR Alters Angiography-Based Management Plans for Stable Angina

Yael L. Maxwell

May 20, 2015

Presentation EuroPCR 2015

Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients

Presenter: Sigmund Silber

May 19, 2015

News Conference News EuroPCR 2015

NOTION: 2-Year Data Show Positive Outlook for TAVR in Lower-Risk Patients

Yael L. Maxwell

May 19, 2015

News Conference News EuroPCR 2015

Evolving DES Technology May Benefit Diabetic Patients

Caitlin E. Cox

May 19, 2015

News Conference News EuroPCR 2015

DEFER at 15 Years: Postponing PCI Based on FFR in Stable Angina Lowers MI Risk

Yael L. Maxwell

May 19, 2015

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

Nobori BES Demonstrates Good Long-term Outcomes with No Stent Thrombosis Beyond 3 Years

Yael L. Maxwell

May 23, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Conference News EuroPCR 2014

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

Yael L. Maxwell

May 21, 2014

News Conference News EuroPCR 2014

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Caitlin E. Cox

May 21, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

News Conference News EuroPCR 2014

APPOSITION IV: Self-Expanding SES Covers Struts Better, Faster than Balloon-Expandable DES

Yael L. Maxwell

May 20, 2014

Presentation EuroPCR 2013

Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Presenter: 203171|Ian Meredith

May 31, 2013

Presentation EuroPCR 2013

Clinical, Angiographic and IVUS Outcomes of the NG PROMUS Clinical Trial Evaluating the Novel Promus PREMIER Stent

Presenter: 228635|John Ormiston

May 31, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Conference News EuroPCR 2013

Side Branch Dilatation Helpful Before T-Stenting of Bifurcation Lesions

Caitlin E. Cox

May 24, 2013

News Conference News EuroPCR 2013

ORBIT II: Atherectomy System Shows Positive Results in Calcified Lesions

Jason Kahn

May 24, 2013

News Conference News EuroPCR 2013

RIPCORD Study: FFR Results Change Path of Patient Management

Caitlin E. Cox

May 23, 2013

News Conference News EuroPCR 2013

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Yael L. Maxwell

May 23, 2013

Advertisement

CT-Derived FFR Alters Angiography-Based Management Plans for Stable Angina

Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients

NOTION: 2-Year Data Show Positive Outlook for TAVR in Lower-Risk Patients

Evolving DES Technology May Benefit Diabetic Patients

DEFER at 15 Years: Postponing PCI Based on FFR in Stable Angina Lowers MI Risk

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Nobori BES Demonstrates Good Long-term Outcomes with No Stent Thrombosis Beyond 3 Years

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

APPOSITION IV: Self-Expanding SES Covers Struts Better, Faster than Balloon-Expandable DES

Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Clinical, Angiographic and IVUS Outcomes of the NG PROMUS Clinical Trial Evaluating the Novel Promus PREMIER Stent

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Side Branch Dilatation Helpful Before T-Stenting of Bifurcation Lesions

ORBIT II: Atherectomy System Shows Positive Results in Calcified Lesions

RIPCORD Study: FFR Results Change Path of Patient Management

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content